The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical manufacturing.

On November 17, 2025, Biohaven's Chief Accounting Officer, George Clark, acquired 17,000 shares of company stock. The Chief ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

UC Davis nematologists, including Valerie Williamson, professor emerita in the Department of Plant Pathology, and associate ...

Learn more about whether Aurinia Pharmaceuticals Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades ...

A South Korean biotechnology company is building a Baltimore manufacturing facility that will bring 500 new jobs to the region.

The annual workforce development conference, held Nov. 13 at Roxbury Community College, covered topics including reskilling ...

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced a ...

A major fund just opened a multimillion-dollar position in ImmunityBio—and the move could hint at rising confidence in this ...

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...